Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA as a Potential Therapeutic Molecule in Cancer
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
Cells (2022) Vol. 11, Iss. 6, pp. 1008-1008
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

miRNAs: The Road from Bench to Bedside
Giuseppe Iacomino
Genes (2023) Vol. 14, Iss. 2, pp. 314-314
Open Access | Times Cited: 48
Screening of miRNAs as prognostic biomarkers and their associated hub targets across Hepatocellular carcinoma using survival-based bioinformatics approach
Prithvi Singh, Rubi Solanki, Alvea Tasneem, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 1, pp. 100337-100337
Open Access | Times Cited: 20
Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA
Joanna Szczepanek, Monika Skorupa, Joanna Jarkiewicz‐Tretyn, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7235-7235
Open Access | Times Cited: 38
The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application
Juan P. Muñoz, Pablo Ernesto Pérez, Yasmín P. Pérez, et al.
Diagnostics (2023) Vol. 13, Iss. 19, pp. 3072-3072
Open Access | Times Cited: 30
Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review
Masaoki Ito, Yoshihiro Miyata, Morihito Okada
Translational Oncology (2023) Vol. 31, pp. 101634-101634
Open Access | Times Cited: 23
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma
David Valle‐García, Verónica Pérez de la Cruz, Itamar Flores, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2464-2464
Open Access | Times Cited: 11
Emerging Strategies to Overcome Chemoresistance: Structural Insights and Therapeutic Targeting of Multidrug Resistance-Linked ATP-Binding Cassette Transporters
Raghavendra Sashi Krishna Nagampalli, Gangadhar P. Vadla, Nadendla EswarKumar
International Journal of Translational Medicine (2025) Vol. 5, Iss. 1, pp. 6-6
Open Access | Times Cited: 1
Altered microRNA Expression Correlates with Reduced TLR2/4-Dependent Periodontal Inflammation and Bone Resorption Induced by Polymicrobial Infection
Syam Praveen Kumar Jeepipalli, Parvathi Gurusamy, A. Martins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access | Times Cited: 1
MicroRNA dysregulations in Merkel cell carcinoma: Molecular mechanisms and clinical applications
Chiara Mazziotta, Christian Felice Cervellera, Carmen Lanzillotti, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 33
Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy
Alina A. Bagdasaryan, Vladimir N. Chubarev, Е. А. Smolyarchuk, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5436-5436
Open Access | Times Cited: 26
MicroRNAs in Cancer and Cardiovascular Disease
Mirolyuba Ilieva, Riccardo Panella, Shizuka Uchida
Cells (2022) Vol. 11, Iss. 22, pp. 3551-3551
Open Access | Times Cited: 23
MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications
Joanna Szczepanek, Andrzej Tretyn
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1590-1590
Open Access | Times Cited: 13
Turmeric Inhibits MDA-MB-231 Cancer Cell Proliferation, Altering miR-638-5p and Its Potential Targets
Murat Kaya, Asmaa Abuaısha, İlknur Süer, et al.
Meme sağlığı dergisi/Meme sağlığı dergisi (2024) Vol. 20, Iss. 2, pp. 102-109
Open Access | Times Cited: 5
Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors
Saade Abdalkareem Jasim, Abdulrahman T. Ahmed, Aziz Kubaev, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 4
MiRNAs: main players of cancer drug resistance target ABC transporters
Forogh Mohammadi, Masoumeh Nejatollahi, Farhad Sheikhnia, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
miR-122 shows potential as a biomarker and therapeutic target in NSCLC by inhibiting WNT/β-catenin and PI3K/AKT pathways and key transcription factors linked to EMT and metastasis
Amirbahador Abasifarid, Ruhollah Dorostkar, Majdedin Ghalavand
Heliyon (2025), pp. e42961-e42961
Open Access
MTFR2 promotes endometrial carcinoma cell proliferation and growth via the miR-132-3p/PI3K/Akt signaling pathway
Zhijun Niu, Yue Zhang, Yishan Wang, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
A three-way junction-mediated SDA cascade CHA system for miRNA detection
Yanheng Yao, Murilege Chao, Feifan Yin, et al.
Talanta (2025), pp. 128033-128033
Closed Access
Association of genetic variants in MIR17HG and in the promoter of MIR17HG with susceptibility to cancer in Chinese Han population: a systematic review and meta-analysis
Binghua Tong, Zhaonan Zhang, Zhaowei Xu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
MicroRNA-142-3p Overcomes Drug Resistance in Hepatocellular Carcinoma by Targeting YES1 and TWF1
Khadijeh Mahboobnia, Tasnuva D. Kabir, Rui Hou, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4161-4161
Open Access
Nucleic acid-based artificial nanocarriers for gene therapy
Longyi Zhu, Jun Luo, Kewei Ren
Journal of Materials Chemistry B (2022) Vol. 11, Iss. 2, pp. 261-279
Closed Access | Times Cited: 17
The role of exo‐miRNA in diagnosis and treatment of cancers, focusing on effective miRNAs in colorectal cancer
H.H.K. Al-Shukri, Sana Ali, Karam Akram Al‐Akkam, et al.
Cell Biology International (2024) Vol. 48, Iss. 3, pp. 280-289
Closed Access | Times Cited: 3
How MicroRNAs Command the Battle against Cancer
Hong Wu, Sarah Leng, Consolato Sergi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5865-5865
Open Access | Times Cited: 3
Etiologically Significant microRNAs in Hepatitis B Virus-Induced Hepatocellular Carcinoma
Krishnapriya Ramakrishnan, Riya Vishwakarma, Radul R. Dev, et al.
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 6, pp. 280-290
Closed Access | Times Cited: 3
Multilevel Mechanisms of Cancer Drug Resistance
Małgorzata Roszkowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12402-12402
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top